The US Food and Drug Administration (FDA) has granted 510(k) clearance to Corvida Medical to market its Halo closed system transfer device (CSTD) to aid healthcare professionals in the handling of hazardous drugs.
The device also secured an ONB product code classification from the FDA, demonstrating no escape of hazardous drug or vapour concentration, no transfer of environmental contaminants and prevention of microbial ingress.
The Halo CSTD provides healthcare professionals with an air-tight and leak-proof closed system that is easy-to-use, with fewer pieces and less steps.
Scheduled to be made commercially available later this year, the device features a simple design that improves comfort, while ensuring compatibility with current work procedures.
The CSTDs are said to be capable of protecting healthcare professionals and patients from exposure to hazardous drugs by mechanically prohibiting the transfer of environmental contaminants into the system and the escape of drug or vapour concentrations outside the system.
Corvida Medical president Kent Smith said: "We are focused on developing and introducing products designed to meet critical unmet needs, and have worked closely with thought leaders throughout our product development efforts.
"The feedback on Halo has been phenomenal. Healthcare professionals appreciate Halo’s simplicity and we look forward to introducing it to the market."
According to the company, millions of healthcare workers are being exposed to hazardous drugs every year, which has serious health effects, including cancers, infertility, genetic mutations and other adverse health effects.
Image: The Halo closed system transfer device has been cleared by the FDA to protect healthcare professionals from exposure to hazardous drugs. Photo: courtesy of Barbaricino.